Neotragus moschatus
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA194233 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Scaptochirus moschatus Genome sequencing
| PRJNA1127535 | ENA
Project description:Ovibos moschatus Genome sequencing and assembly
| PRJNA789692 | ENA
Project description:Ovibos moschatus: Genome sequencing
| PRJNA640637 | ENA
Project description:The complete mitochondrial genome of short-faced mole (Scaptochirus moschatus).
| PRJNA769832 | ENA
Project description:Ovibos moschatus (isolate RAN-27) genome sequencing, assembly and chromosomal-level scaffolding
| PRJNA1071053 | ENA
Project description:The short-faced mole (Scaptochirus moschatus) belonging to the family Talpidae in the order Eulipotyphla is a good model for studying adaptive evolution of mammals because of its morphological and ecological characteristics. However, the lack of genome of short-faced mole has hindered previous studies. In this study, we assembled the genome of the short-faced mole based on Illumina, PacBio HiFi and Hi-C sequencing, and acquired the genome of the short-faced mole with the size of 2.17 Gb. 99.6% of the assembled genome were identified as complete BUSCOs, including 90.7% as complete single-copy BUSCOs and 8.9% as complete duplicated BUSCOs. The assembled genome was anchored to 24 chromosomes with an anchor rate of 94.33%, of which the 24th chromosome (Chr 24) probably contained the X and Y chromosomes. A total of 21,139 coding genes were predicted, and 8.58 exons per gene were predicted.
| S-EPMC11876450 | biostudies-literature
Project description:Muskoxen (Ovibos moschatus), a taxonomically unique Arctic species, are increasingly exposed to climate and other anthropogenic changes. It is critical to develop and validate reliable tools to monitor their physiological stress response in order to assess the impacts of these changes. Here, we measured fecal glucocorticoid metabolite (FGM) levels in response to the administration of adrenocorticotropic hormone (ACTH) in the winter (1 IU/kg) and summer (2 IU/kg) using two enzyme immunoassays, one targeting primarily cortisol and the other targeting primarily corticosterone. Fecal cortisol levels varied substantially within and among individuals, and none of the animals in either challenge showed an increase in fecal cortisol following the injection of ACTH. By contrast, two of six (winter) and two of five (summer) muskoxen showed a clear response in fecal corticosterone levels (i.e., maximal percentage increase as compared to time 0 levels > 100%). Increases in fecal corticosterone post-ACTH injection occurred earlier and were of shorter duration in the summer than in the winter and fecal corticosterone levels were, in general, lower during the summer. These seasonal differences in FGM responses may be related to the use of different individuals (i.e., influence of sex, age, social status, etc.) and to seasonal variations in the metabolism and excretion of glucocorticoids, intestinal transit time, voluntary food intake, and fecal output and moisture content. Results from this study support using FGMs as a biomarker of hypothalamic-pituitary-adrenal axis activity in muskoxen, advance our understanding of the physiological adaptations of mammals living in highly seasonal and extreme environments such as the Arctic, and emphasize the importance of considering seasonality in other species when interpreting FGM levels.
| S-EPMC8046187 | biostudies-literature